Streetbeat News

Stock Prices

JNJ

Johnson & Johnson's second interim analysis of the Phase 3 Cartitude-4 study of Carvykti versus standard therapies for relapsed or lenalidomide-refractory multiple myeloma shows statistically significant and clinically meaningful improvement in overall survival.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 11:37 am

PSNY

Polestar shares are trading lower following the company's Q2 deliveries.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 11:36 am

HPQ

IBM

MEI

Wall Street's most accurate analysts have provided their ratings on three high-yielding tech stocks: IBM, HP Inc., and Methode Electronics. These stocks offer dividend yields of over 3%, making them attractive during market turbulence. Recent analyst ratings and company news are highlighted for each stock.

Portfolio Pulse from Avi Kapoor

July 02, 2024 | 11:32 am

AMD

NVDA

PARA

QQQ

SPY

TSLA

US stocks are set for a lower start as traders await key data and speeches, including Tesla's Q2 data and Fed Chair Powell's speech. The Nasdaq Composite closed at a record high, but futures indicate a downturn. Tesla, Nvidia, AMD, and Paramount Global are in focus.

Portfolio Pulse from Shanthi Rexaline

July 02, 2024 | 11:28 am

BTCUSD

USDCUSD

A report by 10x Research explores the recent 4% surge in Bitcoin's price, potentially linked to former President Donald Trump's strong position in the 2024 election race. The report suggests that while Bitcoin could see short-term gains, a drop to $55,000 is possible in the coming weeks. Seasonal trends, technical indicators, and challenges faced by Bitcoin mining companies are also discussed. Increased exchange balances and outflows from Circle's USDC indicate potential selling pressure.

Portfolio Pulse from Murtuza Merchant

July 02, 2024 | 11:22 am

GILT

Gilat Satellite Networks' US-based subsidiary, DataPath, has secured over $9 million in orders to support the Department of Defense and other agencies, leading to a rise in Gilat's share price.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 11:13 am

WOW

WideOpenWest shares are trading lower after Raymond James downgraded the stock from Market Perform to Underperform.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 11:12 am

HUMA

Humacyte shares are rising after the company received Regenerative Medicine Advanced Therapy designation from the FDA for treating advanced peripheral artery disease.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 11:11 am

CKPT

Checkpoint Therapeutics has resubmitted its Biologics License Application (BLA) for cosibelimab to the FDA for the treatment of advanced skin cancer. The resubmission addresses issues raised in a previous complete response letter, which were related to manufacturing and not clinical data. The BLA is supported by positive safety and efficacy results from pivotal studies.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 11:11 am

INCY

Incyte shares are trading lower following a downgrade from BMO Capital, which changed its rating from Market Perform to Underperform and reduced the price target from $52 to $48.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 11:10 am